STE (STE)

$22.1B
Market Cap
31.4
P/E Ratio
1.04
Beta
1.10%
Dividend Yield
Piotroski 8/9Altman Z 5.0 SafeBeneish M -2.60 CleanROIC−WACC -3.0%

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 8/9, Altman Z 5.0 (above 3.0 safe zone threshold).

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The underlying capital allocation efficiency presents a notable constraint, as the return on invested capital of 7.6% falls significantly short of the weighted average cost of capital at 10.6%, resulting in a negative spread that suggests value destruction despite robust profitability metrics. This dynamic is partially offset by strong operational leverage and earnings quality indicators; the Piotroski F-Score of 8/9 and Beneish M-Score of -2.60 signal exceptional financial health with minimal earnings manipulation risk, while an Altman Z-Score of 5.0 confirms a low probability of distress. The DuPont decomposition reveals that equity returns are driven primarily by high net margins at 11.3% rather than asset turnover or leverage, which sits modestly at 1.53x times equity.

Valuation multiples reflect aggressive market expectations for future growth, with the current P/E ratio of 31.4x trading well above typical historical basements and sector averages given the moderate revenue expansion rate of just 6.2% year-over-year. A discounted cash flow analysis implies a fair value of $237 per share; however, this target is predicated on specific growth assumptions that may not materialize if operating leverage fails to improve or if margin compression occurs. The disparity between current pricing and DCF-derived values indicates the market is pricing in significantly higher future returns than currently realized fundamentals support.

Recent insider activity adds a layer of caution to the risk/reward profile, with $734,877 in net selling over the past 90 days suggesting internal stakeholders may be taking profits or reducing exposure ahead of anticipated volatility. While the balance sheet remains secure and earnings quality is high, the combination of negative ROIC-WACC spread and elevated valuation multiples creates a scenario where downside protection relies heavily on continued margin expansion rather than operational efficiency gains.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →8.6%10.6%12.6%
2%$289$212$165
3%$335$237$179
4%$402$269$197

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=10.6%, terminal growth 3%. Fair value $237 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

8/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
5.0
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.60
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

44.0%
Gross Margin
11.3%
Net Margin
7.6%
ROIC
10.6%
WACC
ROIC − WACC Spread: -3.0%— Negative spread.
+6.2%
Revenue Growth (YoY)
+62.5%
Earnings Growth (YoY)
778.0M
Free Cash Flow
28%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

11.3%
Net Profit Margin
NI ÷ Revenue
×
0.54x
Asset Turnover
Revenue ÷ Assets
×
1.53x
Equity Multiplier
Assets ÷ Equity
=
9.3%
Return on Equity
Balanced ROE composition across margins, turnover, and leverage.

Balance Sheet Health

0.53x
Debt / Equity
1.96x
Current Ratio
10.2x
Interest Coverage
1.3x
Net Debt / EBITDA
3.26%
FCF Yield
1.4B
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
$-734,877
Net Selling
0
Buy Transactions
1
Sale Transactions
2026-03-05FELDMANN CYNTHIA LSold 3/8 qtrsGrant$471,887
2026-03-05FELDMANN CYNTHIA LSold 3/8 qtrsSale$734,877
2026-01-02MCGOWAN LINDSEYGrant798 shares

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✓ Beat
Est: $2.60
Act: $2.74
+5.4%
Q3
✓ Beat
Est: $2.26
Act: $2.34
+3.4%
Q2
✓ Beat
Est: $2.35
Act: $2.47
+5.1%
Q1
✗ Miss
Est: $2.53
Act: $2.53
-0.1%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

20.3
Forward P/E
PEG Ratio
3.09
Price/Book
799920
Avg Volume
$269.44
52W High
$204.90
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$2.6B
Tracked Passive Exposure
8
ETFs Holding STE
0.05%
Avg Weight in ETFs
$5.2T
Total ETF AUM

When investors buy or sell ETFs like XHE or SDY, the fund manager is mechanically forced to buy or sell STE shares regardless of STE's individual fundamentals. We estimate $2.6B of passive capital is structurally linked to STE through 8 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in STE to visualize passive redemption contagion across ETFs and collateral stocks.

STE Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
STEEpicenterVTIETFVOOETFSPYETFLLYLow RiskLLYLow RiskJNJLow RiskJNJLow RiskABBVMed Risk
STE Price Drop (%)0

If STE (STE) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies ELI LILLY + CO (LLY) as the most exposed collateral stock, sharing 1 ETFs with STE. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 23 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

STE Ownership Dynamics

Ticker
STE

Float lock-up computed from 23 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

STE Capital Efficiency

How efficiently does STE convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$778M
EBITDA
$1.4B
FCF Conversion
57%
Reinvestment Rate
43%
57% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
7.6%
ROIC − WACC Spread
-3.0%

STE converts 57% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. However, the ROIC-WACC spread is negative (-3.0%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-1213,354$201.85$2.7M
2026-05-07527$214.46$113,020.42
2026-05-01168$216.88$36,435.84
2026-03-2510$221.73$2,217.3
2026-03-23116$220.03$25,523.48
2026-02-1719,304$248.35$4.8M
2026-02-1328,796$244.22$7.0M
2026-02-03398$264.24$105,167.52
2026-02-021,385$262.60$363,701
2026-01-2757$263.13$14,998.41
2026-01-2227$261.18$7,051.86
2026-01-14181$259.87$47,036.47
2026-01-13261$260.77$68,060.97
2026-01-09114$260.68$29,717.52
2026-01-081,353$259.20$350,697.6
2026-01-0644$256.75$11,297
2025-12-22914$254.34$232,466.76
2025-12-1773$253.03$18,471.19
2025-12-0932$261.41$8,365.12
2025-11-245,146$263.29$1.4M
2025-11-21132$256.98$33,921.36
2025-11-13156$267.99$41,806.44
2025-11-1276$266.70$20,269.2
2025-11-102,493$263.77$657,578.61
2025-11-06125$243.18$30,397.5
2025-11-0411,776$237.32$2.8M
2025-11-036,477$235.70$1.5M
2025-10-27622$240.76$149,752.72
2025-10-2411$241.85$2,660.35
2025-10-1573$237.81$17,360.13

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare STE to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.